[Interleukin-5 as a differentiation factor for eosinophilic granulocytes. Its biological effects and potential therapeutic uses].
Kubin
R
R
Präklinische Forschung, Boehringer Mannheim GmbH.
D000818:Animals; D004804:Eosinophils / Q000187:drug effects*; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology; D015848:Interleukin-5 / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D011971:Receptors, Immunologic / Q000737:chemistry; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5; D013329:Structure-Activity Relationship
D015848:Interleukin-5; D011971:Receptors, Immunologic; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5; D015847:Interleukin-4
Interleukin 5 als Differenzierungsfaktor für eosinophile Granulozyten. Biologische Wirkungen und therapeutische Anwendungsmöglichkeiten.